OPSUMIT (Macitentan)
OPSUMIT is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH. WHO Group I) to reduce the risks of disease progression and…
Actelion Pharmaceuticals US, Inc. Products: Prescription Medications Section
Tracleer (Bosentan)
TRACLEER is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): in adults to improve exercise ability and to decrease clinical worsening. Studies…
UPTRAVI (Selexipag)
UPTRAVI is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension (PAH. WHO Group I) to delay disease progression and reduce the risk of…
Veletri (Epoprostenol)
VELETRI is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Studies establishing effectiveness included predominantly…
Zavesca (Miglustat)
ZAVESCA is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild/moderate type 1 Gaucher disease for whom enzyme replacement therapy is…